AIM ImmunoTech Receives NYSE American Noncompliance Notice; Shares Slump After Hours

MT Newswires Live12-18

AIM ImmunoTech (AIM) said Tuesday it received a noncompliance notice from NYSE American for failing to meet continued listing requirements.

The company said it was notified about noncompliance with the minimum required stockholders' equity for a company that has reported losses from continuing operations and net losses in its five most recent fiscal years.

AIM said the notice has no immediate impact on its listing status and does not affect its business operations or its reporting requirements with the US Securities and Exchange Commission.

The company said it has until Jan. 10 to submit a plan to regain compliance.

Shares of the company were down nearly 5% in recent after-hours activity.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment